Acesso livre
Acesso livre

Saúde Pública/Medicina Humanitária

Covid: no Reino Unido, crianças só devem tomar a dose da vacina 12 semanas depois de uma infecção.

19 Nov, 2021 | 12:35h

Covid: Children told to delay jab for 12 weeks after infection – BBC

Relatório original: Joint Committee on Vaccination and Immunisation (JCVI) advice on COVID-19 vaccination in people aged 16 to 17 years: 15 November 2021

Estudo observacional mostra que a efetividade de vacinas mRNA contra internação por Covid-19 entre adultos imunocomprometidos foi menor (77%) do que entre adultos imunocompetentes (90%).

19 Nov, 2021 | 12:33h

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 – CDC Morbidity and Mortality Weekly Report

Conteúdo relacionado: CDC Guidance: Immunocompromised may need a fourth Covid-19 shot.

 

Comentário no Twitter (fio – clique para saber mais)

 

Estudo observacional mostra que as vacinas mRNA estão associadas à efetividade de 85% contra internação por Covid-19.

19 Nov, 2021 | 12:31h

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity – JAMA

Editorial: Understanding Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination – JAMA

Comentário: COVID-19 vaccines 85% effective against hospital cases but weaken over time – TCTMD

Estudo relacionado: Study compares the decline in effectiveness for Moderna, Pfizer, and Janssen vaccines and consequences for mortality.

8 questões sobre as novas pílulas da Merck e da Pfizer contra Covid.

19 Nov, 2021 | 12:28h

8 lingering questions about the new Covid pills from Merck and Pfizer – STAT

Conteúdos relacionados:

COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.

[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.

A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm.

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

Estudo observacional mostra que o monitoramento de pacientes com Covid-19 via mensagens de texto, propiciando que eles relatassem a piora dos sintomas, foi associado a desfechos melhores.

17 Nov, 2021 | 13:10h

Comparative Effectiveness of an Automated Text Messaging Service for Monitoring COVID-19 at Home – Annals of Internal Medicine

Comunicado de imprensa: Automated Texting System Saved Lives Weekly During First COVID Surge – Penn Medicine

Comentários:

Monitoring outpatients by text appeared to reduce mortality from COVID-19 – ACP Internist

Texting saved lives during Covid. What does that mean for health care’s future? – STAT

 

Comentário do autor no Twitter (fio – clique para saber mais)

 

Grandes questões sobre as doses de reforço das vacinas contra Covid-19 – “Desde o porquê até para quem, ainda precisamos de muitas respostas sobre as doses de reforço.”

17 Nov, 2021 | 13:06h

The big questions about Covid-19 booster shots – Vox

 

Comentário no Twitter

 

Pílula da Pfizer contra COVID deve ser fabricada e vendida mais barata em 95 países pobres.

17 Nov, 2021 | 13:03h

Pfizer COVID Pill to Be Made, Sold Cheaply in 95 Poor Countries – HealthDay

Ver também:

Pfizer agrees to license generic versions of its COVID-19 pill — in some countries – NPR

Pfizer and Medicines Patent Pool Reach ‘Ground-breaking’ Voluntary Licensing Deal for New COVID-19 Treatment Pill – Health Policy Watch

Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries – The New York Times (poucos artigos gratuitos por mês)

MSF responde à licença da Pfizer e do Medicines Patent Pool para o novo tratamento da Covid-19 – “O acordo, porém, cobre somente 53% da população mundial e exclui pessoas em diversos países de média renda, deixando esse medicamento promissor fora do alcance de milhões de pessoas.”

17 Nov, 2021 | 13:01h

MSF responds to Pfizer and Medicines Patent Pool license for new Covid-19 treatment – Médecins Sans Frontières

 

Comentário no Twitter

 

Seguimento de longo prazo de estudo randomizado mostrou que bebês que receberam fórmula láctea enriquecida com suplementos ou nutrientes não apresentaram desempenho acadêmico melhor na adolescência.

17 Nov, 2021 | 12:43h

Comunicado de imprensa: Study finds no benefit of enriched formula milks on later academic performance – British Medical Journal

Estudo original: Effect of nutritionally modified infant formula on academic performance: linkage of seven dormant randomised controlled trials to national education data – The BMJ

Editorial: Enriched formula milks and academic performance in later childhood – The BMJ

 

Comentário no Twitter

 

Covid: Áustria impõe lockdown a não vacinados.

16 Nov, 2021 | 12:44h

Covid: Austria introduces lockdown for unvaccinated – BBC

Ver também: Austria orders nationwide lockdown for the unvaccinated – Associated Press

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.